Adagene ADAG
NASDAQ ADAG
$3.57 -0.12 (-3.25%)
As of: Sep 4, 2026 · 3:57 PM EDT

Adagene (ADAG) Assets Average (2020 - 2026)

Adagene (ADAG) posted quarterly Assets Average of $72.4 million for Q4 2025, down 23.82% year-over-year from $95.0 million in Q4 2024, and down 7.06% quarter-over-quarter from $77.9 million in Q2 2025.

Analysis

Adagene (ADAG) Assets Average (2020 - 2026) Analysis & Trends

Adagene (ADAG) has reported Assets Average for 6 consecutive years, with $72.4 million the latest figure, recorded in Q4 2025.

  • In Q4 2025, Assets Average fell 23.82% year-over-year to $72.4 million; the TTM figure through Dec 2025 stood at $72.4 million (down 23.82% YoY), while the FY2025 annual figure was $83.8 million, down 18.28% from the prior year.
  • Assets Average eased to $72.4 million in Q4 2025 per ADAG's latest filing, from $77.9 million in the prior quarter.
  • Across five years, Assets Average topped out at $203.7 million in Q4 2021 and bottomed at $57.9 million in Q4 2023.
  • Historically, Assets Average has averaged $101.3 million across 5 years, with a median of $86.3 million in 2022.
  • Annual changes were most pronounced in 2021 — Assets Average surged 114.24% — and 2022, when it tumbled 62.59%.
  • Adagene's Assets Average stood at $203.7 million in 2021, then sank by 62.59% to $76.2 million in 2022, then dropped by 24.06% to $57.9 million in 2023, then surged by 64.22% to $95.0 million in 2024, then declined by 23.82% to $72.4 million in 2025.
  • Business Quant data shows ADAG's Assets Average at $72.4 million in Q4 2025, $77.9 million in Q2 2025, and $95.0 million in Q4 2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Assets Avg. (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn 26.95 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 41.30 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn -
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn 11.22 Bn
5 Revolution Medicines 44.33 Bn 44.33 Bn - 3.29 Bn
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 8.86 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn 5.34 Bn
8 Royalty Pharma 28.45 Bn 27.61 Bn - 19.82 Bn
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn 2.09 Bn
10 Adagene 211.24 Mn 211.24 Mn - 105.92 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 105.92 Mn
Dec 31, 2025 72.39 Mn
Jun 30, 2025 77.89 Mn
Dec 31, 2024 95.02 Mn
Jun 30, 2024 108.25 Mn
Dec 31, 2023 125.52 Mn
Jun 30, 2023 143.85 Mn
Dec 31, 2022 165.48 Mn
Jun 30, 2022 184.03 Mn
Dec 31, 2021 203.69 Mn
Jun 30, 2021 151.06 Mn
Dec 31, 2020 95.08 Mn